Literature DB >> 36241864

Cuprizone feeding induces swollen astrocyte endfeet.

Petra Fallier-Becker1, Irina Bonzheim1, Friederike Pfeiffer2.   

Abstract

The cuprizone model is a widely used model to study the pathogenesis of multiple sclerosis (MS). Due to the selective loss of mature oligodendrocytes and myelin, it is mainly being used to study demyelination and the mechanisms of remyelination, as well as the efficiency of compounds or therapeutics aiming at remyelination. Although early investigations using high dosages of cuprizone reported the occurrence of hydrocephalus, it has long been assumed that cuprizone feeding at lower dosages does not induce changes at the blood-brain barrier (BBB). Here, by analyzing BBB ultrastructure with high-resolution electron microscopy, we report changes at astrocytic endfeet surrounding vessels in the brain parenchyma. Particularly, edema formation around blood vessels and swollen astrocytic endfeet already occurred after feeding low dosages of cuprizone. These findings indicate changes in BBB function that will have an impact on the milieu of the central nervous system (CNS) in the cuprizone model and need to be considered when studying the mechanisms of de- and remyelination.
© 2022. The Author(s).

Entities:  

Keywords:  Aquaporin-4; Astrocytic endfeet; Cuprizone; Edema; Electron microscopy; Multiple sclerosis; Orthogonal arrays of particles (OAPs)

Year:  2022        PMID: 36241864     DOI: 10.1007/s00424-022-02759-8

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   4.458


  48 in total

1.  Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.

Authors:  Katharina Janssen; Mira Rickert; Tim Clarner; Cordian Beyer; Markus Kipp
Journal:  Mol Neurobiol       Date:  2015-02-08       Impact factor: 5.590

Review 2.  The astrocyte in multiple sclerosis revisited.

Authors:  Celia F Brosnan; Cedric S Raine
Journal:  Glia       Date:  2013-01-16       Impact factor: 7.452

Review 3.  Multiple sclerosis animal models: a clinical and histopathological perspective.

Authors:  Markus Kipp; Stella Nyamoya; Tanja Hochstrasser; Sandra Amor
Journal:  Brain Pathol       Date:  2017-01-11       Impact factor: 6.508

Review 4.  Multiple Sclerosis Pathology.

Authors:  Hans Lassmann
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

5.  Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood-brain barrier.

Authors:  E J McMahon; D N Cook; K Suzuki; G K Matsushima
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

6.  Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.

Authors:  Péter Acs; Sámuel Komoly
Journal:  Ideggyogy Sz       Date:  2012-07-30       Impact factor: 0.427

7.  Blood-brain barrier permeability during Cuprizone-induced demyelination. Implications for the pathogenesis of immune-mediated demyelinating diseases.

Authors:  D A Bakker; S K Ludwin
Journal:  J Neurol Sci       Date:  1987-04       Impact factor: 3.181

8.  Animal models of multiple sclerosis.

Authors:  Roberto Furlan; Carmela Cuomo; Gianvito Martino
Journal:  Methods Mol Biol       Date:  2009

Review 9.  The cuprizone model for demyelination.

Authors:  O Torkildsen; L A Brunborg; K-M Myhr; L Bø
Journal:  Acta Neurol Scand Suppl       Date:  2008

10.  Cuprizone [bis(cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes.

Authors:  Karelle Bénardais; Alexandra Kotsiari; Jelena Skuljec; Paraskevi N Koutsoudaki; Viktoria Gudi; Vikramjeet Singh; Franca Vulinović; Thomas Skripuletz; Martin Stangel
Journal:  Neurotox Res       Date:  2013-02-08       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.